Clinical trial
Study Evaluating Prevenar in High-Risk Children
NCT00234338 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00234338 |
|---|---|
| Title | Study Evaluating Prevenar in High-Risk Children |
| Official title | Prospective Post-Marketing Surveillance Study of Prevenar in High-Risk Children Aged 2 to 5 Years |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Pneumococcal Disease |
| Enrollment | 5,000 |
| Start date | Oct 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Oct 6, 2005 |
| Last update posted | Dec 10, 2007 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: